Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors

Everolimus is a valid therapeutic option for neuroendocrine tumors (NETs); however, data in a real-world setting outside regulatory trials are sparse. The aim of this study was to determine everolimus tolerability and efficacy, in relation to previous treatments, in a compassionate use program. A to...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Panzuto, Francesco, Rinzivillo, Maria, Fazio, Nicola, de Braud, Filippo, Luppi, Gabriele, Zatelli, Maria Chiara, Lugli, Francesca, Tomassetti, Paola, Riccardi, Ferdinando, Nuzzo, Carmen, Brizzi, Maria Pia, Faggiano, Antongiulio, Zaniboni, Alberto, Nobili, Elisabetta, Pastorelli, Davide, Cascinu, Stefano, Merlano, Marco, Chiara, Silvana, Antonuzzo, Lorenzo, Funaioli, Chiara, Spada, Francesca, Pusceddu, Sara, Fontana, Annalisa, Ambrosio, Maria Rosaria, Cassano, Alessandra, Campana, Davide, Cartenì, Giacomo, Appetecchia, Marialuisa, Berruti, Alfredo, Colao, Annamaria, Falconi, Massimo, Delle Fave, Gianfranco
التنسيق: Artigo
اللغة:Inglês
منشور في: AlphaMed Press 2014
الموضوعات:
Gastrointestinal Cancer
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153458/
https://ncbi.nlm.nih.gov/pubmed/25117065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0037
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة